
|Videos|October 16, 2017
What Unique Challenges Does AllianceRx Walgreens Prime Face?
Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses challenges associated with combining specialty pharmacy operations.
Advertisement
Wright: We are a new company that combines the specialty pharmacies from Prime Therapeutics and Walgreens Specialty Pharmacy. So, our challenges are around how do we bring these 2 strong models together and pick the best of each piece and utilize the best pieces of the platform.
Of course, any specialty pharmacy that were to launch has limited distribution networks to navigate, payer networks to navigate, as well as all of the adherence [challenges]—we are in a highly regulated environment—and to make sure we are actually driving value in that space.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Trump Executive Order Recommends Separating MMR Into 3 Shots
2
The Inflation Reduction Act and Oncology Drug Pricing: What Pharmacists Need to Know
3
Suzetrigine-Based Multimodal Therapy Enables Opioid-Free Recovery in Patients Receiving Surgery
4
FDA Fast Tracks First-in-Class TNFR2 Antibody as Chemotherapy-Free Strategy for Platinum-Resistant Ovarian Cancer
5




































































































